Results 341 to 350 of about 844,749 (403)
S‐ketamine binds directly to SIRT2, facilitating its interaction with NF‐κB p65. This interaction reduces the acetylation of NF‐κB p65 and inhibits its activation, thereby exerting anti‐inflammatory and antidepressant effects. Created by BioRender.
Cong Lin+7 more
wiley +1 more source
Lysine crotonylation in disease: mechanisms, biological functions and therapeutic targets. [PDF]
Ji Y+7 more
europepmc +1 more source
Under DNA damage, tumor cells rely on efficient DNA repair for survival and therapy resistance. This study has demonstrated that BCKDK localizes to breast cancer cell nuclei, where it binds to and phosphorylates RNF8, thereby blocking ubiquitin‐mediated degradation of RAD51 and enhancing HRR. A selective BCKDK inhibitor synergizes with clinical agents,
Haiying Liu+12 more
wiley +1 more source
Physical exercise and epigenetic modifications in skeletal muscle, brain, and heart. [PDF]
Zheng X+8 more
europepmc +1 more source
RNA modification is crucial in fibrosis diseases, but the role of m1A modification remains elusive. This study reveals that ALKBH3, an m1A demethylase, drives skin fibrosis by reshaping m6A RNA modification and stabilizing COL1A1 and FN1 mRNAs through METTL3, uncovering a crosstalk between m1A and m6A methylation in pathological events.
Liying Tu+9 more
wiley +1 more source
The Yeast HMGB Protein Hmo1 Is a Multifaceted Regulator of DNA Damage Tolerance. [PDF]
Huo J, Wei A, Guo N, Wang R, Bi X.
europepmc +1 more source
Ethylene‐activated MdEAEL1 mediates the disassembly of the MdZFP3‐MdTPL4‐MdHDA19 transcriptional repression complex, upregulating the histone acetylation levels in the promoter regions of cell wall degradation‐related genes, consequently promoting softening during storage.
Tong Li+8 more
wiley +1 more source
Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential. [PDF]
Zhou Y+6 more
europepmc +1 more source
PRMT1 drives carboplatin resistance and tumor progression in head and neck squamous cell carcinoma (HNSCC) through a novel, methyltransferase‐independent mechanism. It recruits the SWI/SNF complex to activate IGF2BP2, promoting tumor growth and carboplatin resistance. PBX2 upregulates PRMT1, reinforcing this pathway. This study uncovers a non‐catalytic
Shixian Liu+22 more
wiley +1 more source
Lactylation in CNS disorders: mechanisms, cellular function, and disease relevance. [PDF]
Tian J+7 more
europepmc +1 more source